BamSEC and AlphaSense Join Forces
Learn More

Nexalin Technology Inc. – Material Contracts

NASDAQ: NXL    
Share price (10/20/26): $2.14    
Market cap (10/20/26): $2.244 million

Material Contracts Filter

EX-10.1
from 8-K 28 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) the Type That the Registrant Treats as Private or Confidential. [***] Indicates That Information Has Been Excluded
12/34/56
EX-10.3
from S-8 7 pages Nexalin Technology, Inc. 2026 Equity Incentive Plan Stock Option Grant Notice
12/34/56
EX-10.2
from S-8 11 pages Nexalin Technology, Inc. 2023 Equity Incentive Plan
12/34/56
EX-10.2
from 8-K 5 pages Promissory Note
12/34/56
EX-10.1
from 8-K 18 pages Note Purchase Agreement
12/34/56
EX-10.2
from 8-K 34 pages Specific Terms in This Exhibit Have Been Redacted Because Such Terms Are Both Not Material and Are the Type That the Registrant Treats as Private or Confidential. These Redacted Terms Have Been Marked in This Exhibit With Three Asterisks as [***]. Any Market Purchase Agreement
12/34/56
EX-10.1
from 8-K 35 pages Specific Terms in This Exhibit Have Been Redacted Because Such Terms Are Both Not Material and Are the Type That the Registrant Treats as Private or Confidential. These Redacted Terms Have Been Marked in This Exhibit With Three Asterisks as [***]. Securities Purchase Agreement
12/34/56
EX-10.5
from 10-Q 10 pages Certain Information Identified by Bracketed Asterisks ([***]) Has Been Omitted From This Exhibit Because It Is Both Not Material and Is the Type of Information the Registrant Treats as Private or Confidential. Third Amendment to Office Lease
12/34/56
EX-10.4
from 10-Q 16 pages A. Ponm Is a Wholly-Owned Subsidiary of Glv, Formerly Known as Project Obot Network Management, LLC, a North Carolina Limited Liability Company, B. the Parties Desire to Replace the Existing Contribution and License Agreement, Dated August 1, 2025, and Associated Addendum No. 1, Between the Parties With This Agreement. C. the Parties Further Desire That Ponm Obtain an Exclusive License With Respect to Certain Uses (“The Ponm Field of Use”) of the Licensed Software (Defined Below) Owned by Glv as Described in This Agreement and Identified on Appendix a and Related Documentation. D. Glv Shall Grant to Ponm Such Exclusive License to the Licensed Software. Now, Therefore, in Consideration of the Foregoing, the Mutual Covenants and Undertakings Contained in Contained in This Agreement, and Other Good and Valuable Consideration, the Receipt and Sufficiency of Which Are Hereby Acknowledged, the Parties Hereby Agree as Follows: 1. Definitions
12/34/56
EX-10.3
from 10-Q 13 pages Certain Information Identified by Bracketed Asterisks ([***]) Has Been Omitted From This Exhibit Because It Is Both Not Material and Is the Type of Information the Registrant Treats as Private or Confidential. Collaboration Agreement
12/34/56
EX-10.2
from 10-Q 30 pages Purchase and Sale
12/34/56
EX-10.1
from 10-Q 18 pages Certain Information Identified by Bracketed Asterisks ([***]) Has Been Omitted From This Exhibit Because It Is Both Not Material and Is the Type of Information the Registrant Treats as Private or Confidential
12/34/56
EX-10.26
from 10-K 6 pages Nexalin Technology, Inc. 2023 Equity Incentive Plan Notice of Stock Option Grant
12/34/56
EX-10.1
from 8-K 4 pages Nexalin Technology, Inc. Amendment No. 2 to Equity Distribution Agreement
12/34/56
EX-10.1
from 8-K 7 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 34 pages Underwriting Agreement
12/34/56
EX-10.1
from 8-K 3 pages Nexalin Technology, Inc. Amendment No. 1 to Equity Distribution Agreement
12/34/56
EX-10.19
from S-1 5 pages Supplier Quality Agreement
12/34/56
EX-10.1
from 8-K 2 pages September 3, 2024 Ms. Carolyn Shelton Re: Terms of Employment Dear Carolyn, We Are Very Excited at the Prospect of Your Joining Nexalin Technology, Inc. (The “Company”). Our Offer of Employment Is for the Position Listed Below and Is Subject to the Following Terms and Conditions: 1. Title/Position. Senior Vice President Quality, Regulatory, and Clinical Affairs. 2. Salary. Base Annual Salary of $300,000
12/34/56
EX-10.1
from 8-K 15 pages Placement Agency Agreement
12/34/56